Fresenius Medical Care AG (FMCQF)
FMCQF is quoted over the counter, not listed on an exchange. Fresenius Medical Care AG files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | FMCQF, quoted over the counter |
| SEC CIK | 0001333141 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Services-Misc Health & Allied Services, NEC |
| Business address | Bad Homburg, Germany |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-02-24 |
| Cash and burn | $1.8B cash; operating cash flow $740.8M a quarter. | Report 2025-12-31 |
| Shares outstanding | No cover-page share count in XBRL | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft, Frankfurt, Germany | PCAOB Form AP 2026-03-12 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $21.7B | $1.1B | $3.0B | $1.8B | $11.9B | $21.7B | 20-F 2026-02-24 |
| FY 2016 2016-12-31 | Not filed | $1.2B | $2.1B | $747.2M | $8.6B | Needs four quarters | 20-F 2017-02-22 |
| FY 2015 2015-12-31 | Not filed | $1.0B | $2.0B | $549.5M | $8.6B | Needs four quarters | 20-F 2017-02-22 |
| FY 2014 2014-12-31 | $5.3B | $1.0B | $1.9B | $633.9M | $9.5B | $5.3B | 20-F 2015-02-25 |
| FY 2013 2013-12-31 | $5.0B | $1.1B | $2.0B | $682.8M | $8.4B | $5.0B | 20-F 2014-02-25 |
| FY 2012 2012-12-31 | Not filed | $1.2B | $2.0B | $688.0M | $8.2B | Needs four quarters | 20-F 2015-02-25 |
| FY 2011 2011-12-31 | Not filed | $1.1B | $1.4B | $457.3M | $7.2B | Needs four quarters | 20-F 2014-02-25 |
| FY 2010 2010-12-31 | Not filed | $978.5M | $1.4B | $522.9M | $4.7B | Needs four quarters | 20-F 2013-02-26 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2023-06-06 |
| Latest annual report | 20-F | 2026-02-24 |
| Latest quarterly / interim | 6-K | 2026-11-09 |
Source: SEC EDGAR submissions feed, 602 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier